Filtered By:
Condition: Diabetes
Vaccination: Hepatitis Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 67 results found since Jan 2013.

Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States
CONCLUSION: The recently approved 3-antigen vaccine is a cost-saving or cost-effective intervention for preventing HBV infection and addressing the long-standing burden of hepatitis B among US adults.PMID:37147201 | DOI:10.1016/j.vaccine.2023.04.022
Source: Vaccine - May 5, 2023 Category: Allergy & Immunology Authors: Sandra E Talbird Seri A Anderson Misha Nossov Nell Beattie Aaron T Rak Francisco Diaz-Mitoma Source Type: research

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China
CONCLUSIONS: It was gradually increased that age, the proportion of females, non-viral hepatitis-related causes, AFP-negative, and abnormal glucose/lipids among PLC patients. Proper control of glucose/lipids or ALT may improve the prognosis of PLCs.PMID:36998463 | PMC:PMC10043326 | DOI:10.3389/fonc.2023.1109980
Source: Cancer Control - March 31, 2023 Category: Cancer & Oncology Authors: Yezhou Ding Mingyang Feng Di Ma Gangde Zhao Xiaolin Wang Baoyan An Yumin Xu Shike Lou Lanyi Lin Qing Xie Kehui Liu Shisan Bao Hui Wang Source Type: research

Fight Aging! Newsletter, February 13th 2023
This study investigated whether taller Polish adults live longer than their shorter counterparts. Data on declared height were available from 848,860 individuals who died in the years 2004-2008 in Poland. To allow for the cohort effect, the Z-values were generated. Separately for both sexes, Pearson's r coefficients of correlation were calculated. Subsequently, one way ANOVA was performed. The correlation between adult height and longevity was negative and statistically significant in both men and women. After eliminating the effects of secular trends in height, the correlation was very weak (r = -0.0044 in men and ...
Source: Fight Aging! - February 12, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China
This article is protected by copyright. All rights reserved.PMID:36571260 | DOI:10.1002/jmv.28434
Source: Cancer Control - December 26, 2022 Category: Cancer & Oncology Authors: Hu Li Dachuan Cai Depeng Jiang Xingsheng Li Xiaohui Liao Dongfang Liu Zuojin Liu Peng Zhu Guobing Yin Jia Ming Mingli Peng Min Chen Ning Ling Yinghua Lan Dazhi Zhang Peng Hu Hong Ren Source Type: research

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt
CONCLUSION: HCV infection and its complications significantly impair HBV vaccine response. Levels of anti-HBs Abs decline progressively with increasing duration from the last dose in immunization schedule of HBV vaccine. Diabetes and presence of cirrhosis being the main risk factors for vaccine hypo-responsiveness, also oral DAAs therapy is associated with reduced response to HBV vaccine.PMID:36209916 | DOI:10.1016/j.virusres.2022.198953
Source: Virus Research - October 9, 2022 Category: Virology Authors: Alshymaa A Hassnine Mona A Saber Yasser M Fouad Hatem Sarhan Mahmoud Ma Elsayed Zaki M Zaki Ehab M Abdelraheem Safaa M Abdelhalim Amr M Elsayed Source Type: research

Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece
CONCLUSIONS: Vaccination rates of patients with T2D show an increasing trend, especially for influenza and S. pneumoniae, although the one for S. pneumoniae was low. Older people seem more prone to vaccination, the one for herpes zoster was low with infected patients remaining unvaccinated while significantly low coverage was observed for other VPDs. The findings are important to improve effectiveness of preventative services.PMID:35979460 | PMC:PMC9376377 | DOI:10.3389/fpubh.2022.921243
Source: Herpes - August 18, 2022 Category: Infectious Diseases Authors: Georgios Galanos Helen Dimitriou Angelos Pappas Chrysoula Perdikogianni Emmanouil K Symvoulakis Emmanouil Galanakis Christos Lionis Source Type: research

Vaccination coverage among older adults: a population-based study in India
CONCLUSION: Targeted policies and programmes are needed for improving the low vaccination coverage among older adults in India, especially among those with chronic diseases. Further research could examine vaccine access, vaccine hesitancy, and vaccine-related information and communication channels to older adults and their health-care providers.PMID:35694621 | PMC:PMC9178419 | DOI:10.2471/BLT.21.287390
Source: Bulletin of the World Health Organization - June 13, 2022 Category: International Medicine & Public Health Authors: Ali Abbas Rizvi Abhishek Singh Source Type: research